Valentin P. Yakubenko

Valentin P. Yakubenko

Auto-generated profile, based on publicly available information

Valentin P. Yakubenko

Department of Cell Biology, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2008 in Experimental Cell Research
Verified
Journal Article
Closed access
VYValentin P. Yakubenko
Valentin P. Yakubenko
NBNataly Belevych
Nataly Belevych
DMDaria Mishchuk
Daria Mishchuk
ASAleksey Schurin
Aleksey Schurin
SLStephen C.-T. Lam
Stephen C.-T. Lam
TUTatiana P. Ugarova
Tatiana P. Ugarova

4 March 2011 in Circulation Research
Verified
Journal Article
Closed access
PDF file
VYValentin P. Yakubenko
Valentin P. Yakubenko
ABAshish Bhattacharjee
Ashish Bhattacharjee
EPElzbieta Pluskota
Elzbieta Pluskota
MCMartha K. Cathcart
Martha K. Cathcart
Rationale:: The alternative activation of monocytes by interleukin (IL)-13 and IL-4 is a significant component of the inflammatory response. The consequences of alternative activation in inflammatory diseases remain to be determined. Objective:: In this report, we explored how integrins, receptors important for monocyte migration to inflammatory sites, regulate IL-13–mediated monocyte activation. We focused on the analysis of 2 proteins, which are upregulated during the alternative activation and are important for the development of atherosclerosis, an oxidative enzyme 15-lipoxygenase (15-LO) and a scavenger receptor CD36. Methods and Results:: We found that adhesion of resting monocytes through β 2 integrins and inside-out activation of β 2 integrins by monocyte chemoattractant protein-1 did not change IL-13–stimulated 15-LO upregulation; however, preincubation of monocytes with the antibody MEM48, which generates full activation of β 2 integrins, significantly inhibited 15-LO mRNA and protein expression. In contrast, activation of β 1 integrins had no effect on 15-LO expression. Analysis of integrin clustering through α M , α L , α X , and α D subunits demonstrated the pivotal role for integrin α M β 2 in inhibiting 15-LO expression. IL-13 treatment upregulates 15-LO–dependent CD36 expression on human monocytes; our studies showed that β 2 integrin activation and α M integrin clustering significantly inhibited IL-13–dependent CD36 mRNA and protein expression, as well as CD36-related foam cell formation. Moreover, IL-13 stimulation of α M -deficient peritoneal macrophages demonstrated an upregulated level of 15-LO induction, CD36 expression, and lipid accumulation as compared with wild-type controls. Conclusions:: The adhesion of monocytes/macrophages through activated integrin α M β 2 has a regulatory and potential atheroprotective function during the alternative activation of macrophages.